NS-2359

N/A

Report date: 2025/10/02 20:00:08
NME

Base Information

Drug NameNS-2359
Drug Alias NameNS-2359GSK-372475
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitors
TargetsDopamine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive DisorderCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch AsSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch AsGlaxosmithkline PlcSaniona A/S +[5] 
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDepressive DisorderCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank